Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.21
-0.36 (-1.47%)
Apr 10, 2026, 4:00 PM EDT - Market closed

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
ZORYVE Cream 0.3% Revenue
121.00M85.08M
ZORYVE Cream 0.3% Revenue Growth
42.21%191.52%
ZORYVE Foam Revenue
181.89M71.54M
ZORYVE Foam Revenue Growth
154.26%-
ZORYVE Cream 0.15% Revenue
68.27M9.92M
ZORYVE Cream 0.15% Revenue Growth
588.18%-
ZORYVE Cream 0.05% Revenue
911.00K-
Total Product Revenue
372.07M166.54M
Total Product Revenue Growth
123.41%470.62%
Other Segment Revenue
4.00M30.00M
Other Segment Revenue Growth
-86.67%-1.38%
Revenue (Other)
-911.00K-
Revenue (Total)
376.07M196.54M
Revenue (Total) Growth
91.34%229.73%
Updated Feb 25, 2026. Data Source: Fiscal.ai.